
Active Surveillance Studies
Evaluate the probability and frequency of adverse events as part of post-marketing risk assessment for medical products.

Regulatory agencies seek to reduce the impact of adverse events in financial and humanistic terms.
We conduct post-authorization safety studies (PASS) to investigate the frequency of already known adverse events and possible rare adverse events in a patient population that is typical of real-life users. We use the EURAS/INAS study design, which has been internationally recognized as being scientifically and methodically robust.